Quick Facts

Property Value
Category Neuroregulatory Tripeptide
Risk Level Experimental
Administration Subcutaneous Injection
Typical Frequency Twice Daily
Estimated Half-Life Short Plasma Half-Life / Extended Neurological Signaling Discussed
Primary Research Interest Neuroprotection / Cognitive Support / Sleep Regulation
Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and experimental neuroregulatory compounds. Pinealon is a biologically active peptide with limited modern Western clinical validation and incompletely characterized long-term safety data. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

  • Vial Size: 10 mg
  • Dilutant Type: BAC Water
  • Amount of Dilutant Added: 2 mL
  • Final Concentration: 5.00 mg/mL

At this concentration:

• 5 mg = 1.000 mL (100.0 units)

2. Route of Administration

Pinealon is most commonly discussed as a subcutaneous injectable neuroregulatory peptide compound.

  • Primary Route: SubQ Injection
  • Preferred Timing: Morning and evening administration
  • Administration Notes: Some users strongly monitor sleep and dream changes during early exposure periods

3. Typical Research Protocols

  • Product Strength: 5.00 mg/mL
  • Typical Delivered Amount: 5 mg
  • Frequency: BID (twice daily)
  • Cycle Length: 15–30 days on / 5 months off, repeated biannually
  • Special Notes: Research surrounding Pinealon remains limited, particularly in Western scientific literature, because much of the early work originated from Russian-language studies. Anecdotal reports vary widely, though many users describe significant changes in sleep quality and dream intensity. It is commonly recommended to trial the compound for several days before committing to a full cycle in order to assess its effects on sleep patterns.

4. Summary

Pinealon is an experimental tripeptide originally researched for potential neuroprotective, cognitive-supportive, and anti-aging neurological applications.

Research interest in Pinealon primarily centers around cognitive performance, neuronal protection, sleep regulation, and theoretical longevity-associated neurological support.

5. Mechanism of Action

Pinealon is believed to influence neurological signaling pathways associated with neuronal protection, gene expression regulation, oxidative stress response, and cognitive function.

Potential downstream effects discussed in research include:

  • Neuroprotective signaling support
  • Oxidative stress modulation
  • Cognitive performance support
  • Sleep and circadian rhythm alterations
  • Potential anti-aging neurological signaling

Much of the peptide’s reputation originates from experimental Eastern European longevity and neurobiology research.

6. Potential Benefits

  • Potential cognitive support
  • Possible neuroprotective effects
  • Improved sleep quality in anecdotal reports
  • Enhanced dream vividness in anecdotal reports
  • Potential oxidative stress reduction
  • Theoretical longevity-supportive neurological signaling

7. Potential Risks / Side Effects

Experimental

  • Limited modern human safety data
  • Sleep disruption or abnormal dreams
  • Fatigue or lethargy
  • Headaches
  • Dizziness
  • Unknown long-term neurological effects
  • Potential circadian rhythm disruption

8. Half-Life

Pinealon is believed to have a relatively short circulating plasma half-life.

However, many proposed neurological effects may persist beyond the peptide’s detectable circulation period due to downstream signaling mechanisms.

9. Storage Information

  • Store refrigerated before and after reconstitution
  • Protect from direct light exposure
  • Avoid repeated freeze-thaw cycles
  • Maintain sterile handling practices during preparation

10. Contraindications / Warnings

  • Pregnancy or breastfeeding
  • Severe neurological disorders
  • Uncontrolled psychiatric conditions
  • Known hypersensitivity to peptide compounds

11. Research References

  • PubMed
  • Russian peptide research literature
  • Experimental neurobiology publications
  • Peer-reviewed longevity and cognition journals